Glaukos CorporationGlaukos CorporationGlaukos Corporation

Glaukos Corporation

No trades
See on Supercharts
Market capitalization
‪4.86 B‬USD
−2.78USD
‪−134.66 M‬USD
‪314.71 M‬USD
‪47.33 M‬
Beta (1Y)
0.82

About Glaukos Corporation

CEO
Thomas William Burns
Headquarters
Aliso Viejo
Employees (FY)
907
Founded
1998
ISIN
US3773221029
FIGI
BBG000WG2LQ1
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GKOS is 96.84 USD — it has decreased by 1.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Glaukos Corporation stocks are traded under the ticker GKOS.
Glaukos Corporation is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Glaukos Corporation has a max estimate of 120.00 USD and a min estimate of 84.00 USD.
GKOS earnings for the last quarter are −0.50 USD whereas the estimation was −0.55 USD which accounts for 9.12% surprise. Estimated earnings for the next quarter are −0.55 USD. See more details about Glaukos Corporation earnings.
Glaukos Corporation revenue for the last quarter amounts to ‪78.05 M‬ USD despite the estimated figure of ‪75.25 M‬ USD. In the next quarter revenue is expected to reach ‪81.00 M‬ USD.
Yes, you can track Glaukos Corporation financials in yearly and quarterly reports right on TradingView.
Like other stocks, GKOS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Glaukos Corporation stock right from TradingView charts — choose your broker and connect to your account.
GKOS reached its all-time high on Apr 9, 2024 with the price of 102.33 USD, and its all-time low was 14.25 USD and was reached on Feb 8, 2016.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 907.00 employees. See our rating of the largest employees — is Glaukos Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Glaukos Corporation EBITDA is ‪−79.52 M‬ USD, and current EBITDA margin is −27.24%. See more stats in Glaukos Corporation financial statements.